From cell culture to immunoassays, fluorescent-detected immunoassays and molecular diagnostics, Quidel continues to expand on Point-of-Care (POC) testing solutions to address the needs of physicians and laboratorians globally. In 38 years, our offerings have grown from the early introduction of QuickVue® pregnancy tests into an innovative medical diagnostics portfolio covering respiratory, women’s health/STD, eye health, cardiovascular, hospital-acquired infection, gastrointestinal, thyroid, and drug screening. While the business was built on the QuickVue brand, Quidel currently has over a dozen other brands including 100+ different products with hundreds of SKUs ranging from easy-to-use CLIA-waived dipsticks to complex cell-based assays and PCR reagents.
ACC.20/WCC Learning Pathways? (select all that apply) Acute and Stable Ischemic Heart Disease, Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Prevention, Pulmonary Hypertension